MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Aratana Therapeutics Company Profile (NASDAQ:PETX)

Consensus Ratings for Aratana Therapeutics (NASDAQ:PETX) (?)
Ratings Breakdown: 1 Hold Rating(s), 9 Buy Rating(s)
Consensus Rating:Buy (Score: 2.90)
Consensus Price Target: $19.63 (632.28% upside)

Analysts' Ratings History for Aratana Therapeutics (NASDAQ:PETX)
Show:
DateFirmActionRatingPrice TargetActions
2/3/2016Credit SuisseInitiated CoverageOutperform$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/20/2016Jefferies GroupReiterated RatingBuy$18.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/2/2015BarclaysReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/30/2015BarclaysLower Price TargetOverweight$30.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/19/2015Stifel NicolausReiterated RatingBuy$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/4/2015Piper JaffrayReiterated RatingOverweight$25.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/29/2015Jefferies GroupLower Price TargetBuy$29.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/25/2015Craig HallumDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/29/2015Lake Street CapitalInitiated CoverageBuy$28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2015Piper JaffrayReiterated RatingOverweight$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2015JMP SecuritiesSet Price TargetBuy$38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2015Bank of AmericaBoost Price Target$26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2015Stifel NicolausBoost Price TargetBuy$19.00 -> $23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/24/2015Bank of AmericaInitiated CoverageBuy$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2015William BlairReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/5/2014Jefferies GroupReiterated RatingBuy$23.00 -> $21.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/6/2014Piper JaffrayInitiated CoverageOverweight$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/6/2014Jefferies GroupReiterated RatingBuy$25.00 -> $23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/14/2014Stifel NicolausReiterated RatingBuy$30.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/24/2014Jefferies GroupInitiated CoverageBuy$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/10/2014Stifel NicolausReiterated RatingBuy$30.00 -> $33.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/10/2014BarclaysInitiated CoverageOverweight$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 2/9/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by the American Association of Individual Investors As Featured by Seeking Alpha